Baoy, Ziah D.
HRN: 24-24-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2023
CEFTRIAXONE 1G (VIAL)
12/12/2023
12/19/2023
IV
1g
OD
T/c Bacterial Infection, Unspecified
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes